Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results

Rhea-AI Summary

Optinose (NASDAQ:OPTN) announced that it will report its fourth quarter 2022 financial results and corporate updates on March 7, 2023, before market open. The company, which focuses on patients treated by ENT and allergy specialists, will host a conference call at 8:00 a.m. Eastern Time on the same day. Participants can access the call via a webcast on the company’s website or join by telephone after prior registration. A replay of the event will be available for 60 days following its conclusion.

Conference Call and Webcast to be held March 7, 2023 at 8:00 a.m. Eastern Time

YARDLEY, Pa., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the fourth quarter 2022 and corporate updates, before market open on Tuesday, March 7, 2023.

Company to Host Conference Call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m. Eastern Time on Tuesday, March 7, 2023.

Participants may access the conference call live via webcast by visiting the Investors section of Optinose’s website at http://ir.optinose.com/event-calendar. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a personal PIN that can be used to access the call. In addition, a replay of the webcast will be available on the Company website for 60 days following the event.

About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531

FAQ

What date will Optinose report its financial results for Q4 2022?

Optinose will report its financial results for the fourth quarter of 2022 on March 7, 2023.

What time is the Optinose conference call scheduled for?

The Optinose conference call is scheduled for 8:00 a.m. Eastern Time on March 7, 2023.

How can I access the Optinose conference call?

You can access the Optinose conference call live via webcast on the company's Investors section of their website or by registering for a telephone call.

Will there be a replay of the Optinose conference call?

Yes, a replay of the Optinose conference call will be available for 60 days following the event.